reflection objectives: Obstructive sleep apnea (OSA) is characterized from repeated episodes of upper airways obstruction during repose that result in episodes of hypoxia.

reflection objectives: Obstructive sleep apnea (OSA) is characterized from repeated episodes of upper airways obstruction during repose that result in episodes of hypoxia. An increase of systemic biomarkers of inflammation and oxidative stres has been set in patients with OSA and obesity.

Design: The aim of this close attention was to measure the flats of markers of inflammation (interleukin [IL]-6) and oxidative stres (8-isoprostane) in the exhaled breath condensate of OSA and obese patients.

Patients and methods: Eighteen OSA patients (13 men; mean [[+ or -] SEM] age, 44 [+ or -] 7 years), 10 obese bring under rules (4 men; mean age, 39 [+ or -] 8 years), and 15 healthy age-matched exposes (8 men; mean age, 42 [+ or -] 4 years) were recruited. IL-6 and 8-isoprostane were measured in exhaled breath condensate on a specific enzyme immunoassay kit.

Measurements and results: Higher concentrations of IL-6 were ground in OSA patients (8.7 [+ or -] 03 pg/mL) than in healthy rule subjects (1.6 [+ or -] 01 pg/mL; p < 00001) Obese bring under rules also had higher levels than healthy mastery subjects, but lower levels than OSA patients (21 [+ or -] 02 pg/mL p < 005 and p < 00001 respectively). Furthermore, 8-isoprostane evens were found to be higher in OSA patients (74 [+ or -] 07 pg/mL) than in obese make liables (5 [+ or -] 03 pg/mL; p = 04) and healthy make submissives (4.5 [+ or -] 05 pg/mL; p < 0005) We originate a positive correlation between these sum of two units markers and neck circumference and apnea/hypopnea index.

Conclusions: These findings move that inflammation and oxidative stres are characteristic in the airways of OSA patients yet not in obese subjects, and that their flats depend on the severity of the OSA. The measurement of IL-6 and 8-isoprostane plains may prove to be useful in screening and monitoring obese patients who have a high risk of developing OSA.

elucidation words: 8-isoprostane; interleukin-6; obesity; obstructive nap apnea

Abbreviations: AHI = apnea/hypopnea index; ES = Epworth sleepiness scale; IL = interleukin; OSA = obstructive be still apnea; PG = prostaglandin; TST = total be still time

**********

It is estimated that 2% of women and 4% of men experience obstructive nap apnea (OSA), a condition that is characterized from repeated episodes of upper airways obstruction during be still leading to significant hypoxemia. (1) Consequently in many patients with OSA cyclical alterations of arterial oxygen saturation are observ with oxygen desaturation developing in reply to apnea followed by the resumption of oxygen saturation during hyperventilation. (2) This phenomenon has been referr to as hypoxia/reoxygenation and might alter the oxidative balance by the and of the induction of excess oxygen at liberty radicals, quite like in the sequelae of ischemia/ reperfusion injury. a certain quantity of authors have reported an increase in the horizontals of systemic biomarkers of inflammation and oxidative stres in patients with OSA (34) and obesity, (56) suggesting a possible character in the pathogenesis and pathologic deductions of OSA (eg, cardiovascular complications and cerebrovascular accidents). Upper airway mode of building and function are altered in patients with OSA. (2) In addition, the accumulation of exces fat around the neck of obese enslaves may reduce pharyngeal size, which is an important risk factor for doze apnea. (7) The presence of inflammation and oxidative stres in the small rooms of the upper airways mucosa has been described previously in patients with OSA according to some authors, (8,9) but not from others. (4)

There has been increased interest in the analysis of exhaled gases and condensates as a way of noninvasively monitoring inflammation and oxidative stres in the lung (10) The collection of exhaled breath condensate is a completely noninvasive course which can be repeated repeatedly because the maneuver does not affect the airway function or cause inflammation.

In this research we analyzed the presence of 8-isoprostane, a marker Of oxidative stres (11) and interleukin (IL)-6, a marker of inflammation, (12) in the breath condensate of OSA patients and bring under rules matched for obesity in order to behold whether these markers reflect the severity of OSA and whether they could be used to sieve obese subjects with a high risk of developing OSA.

MATERIALS AND METHODS

Patients

The thought population consisted of 18 OSA patients, 10 enthralls matched for obesity who did not have OSA, and 15 age-matched normal sway subjects (Table 1). All exposes were white and were recruited from the repose laboratory of the Respiratory Disease Institute at University of Bari (Italy). Written informed consensus was obtained from all bring under rules and the institutional ethics committee approved the consideration A complete physical examination was performed, including neurologic, cardiopulmonary, and ear, nose, and throat evaluations. Inclusion criteria for this close attention were an apnea-hypopnea index (AHI) > 20 and symptoms of excessive daytime sleepiness for OSA enthralls and an AHI < 5 for in have charge of and obese subjects. The cluster of control subjects consisted of 15 subdues (eight men; mean [[+ or -] SEM] age, 42 [+ or -] 4 years), of normal weight (body mass index, < 27 kg/[msup2]) with no be still disturbances, and with good health. OSA and obese controls were weight-matched. Both OSA patients and obese controls did not have any of the following conditions: endocrinologic disease; narcolepsy or idiopathic hypersomnia; neuromuscular disease; psychiatric disorders; manifest cardiopulmonary disease; airway obstruction; anatomic maxillomandibular skeletal abnormalities; ear, nose, and throat pathology; or abuse of alcohol or any kind of unsalable article We excluded patients with rhinitis, sinusitis, and respiratory and systemic infections. All enslaves had been ex-smokers for at least 3 month and had undergone no therapy with inhaled, oral, or nasal steroids or with anti-inflammatory physics or [beta]-blockers for 4 weeks prior to the inquiry None of OSA patients used continuous positive airway hurry therapy.

...